T14	Treatment 206 211	CBDCA
T15	Subject 9 20	one patient
T16	Effect 31 99	severe hypersensitivity reactions including cardiac arrest and apnea
T19	Drug 206 211	CBDCA
T20	Subject 113 126	four patients
T21	Effect 137 176	eruptions, hypotension, and tachycardia
